To evaluate the safety and effectiveness of urethra-sparing transperineal radiofrequency ablation for treating benign prostatic hyperplasia.
Conducted as a prospective bicenter outpatient study
Used image guidance for the procedure
Focused on patients with lower urinary tract symptoms related to benign prostatic hyperplasia
Proven to be a safe and feasible treatment option
Demonstrated effectiveness in alleviating lower urinary tract symptoms
Considered a minimally invasive alternative for benign prostatic hyperplasia
Abstract
Urethra-sparing TPTA has proven to be a safe, feasible, and effective treatment for LUTS and may represent a minimally invasive and effective alternative for BPH.